Survey of diplomates of the American College of Veterinary Internal Medicine and the American College of Veterinary Surgeons regarding clinical aspects and treatment of endotoxemia in horses.

This research paper explores the perceptions and practices of veterinary professionals regarding the occurrence, diagnosis, prevention, and treatment of endotoxemia, a serious health issue, in horses. The study is based on a questionnaire distributed to expert equine practitioners.

About the Study

• The study was conducted using a questionnaire aimed at gathering information about prevalence, causes, diagnosis, prevention, treatment and complications of endotoxemia in horses.
• The questionnaire was sent to diplomates of the American College of Veterinary Internal Medicine and the American College of Veterinary Surgeons who are practicing equine medicine.

Common Causes of Endotoxemia

• The survey found that the most common clinical conditions leading to endotoxemia in horses were gastrointestinal tract compromise, conditions related to foaling, and grain overload.

Diagnosis of Endotoxemia

• Most respondents indicated that they diagnose endotoxemia based on several clinical and laboratory findings. These include neutropenia (a decrease in the number of white blood cells), leukopenia (a decrease in the total number of white blood cells), hyperemic mucous membranes (an excess of blood in the horse’s mucous membranes), tachycardia (a rapid heart rate), and fever.

Prevention and Treatment of Endotoxemia

• The survey revealed that the standard treatments used by veterinarians to prevent the development of endotoxemia or treat horses that have endotoxemia are the administration of intravenous fluids, the use of broad-spectrum antimicrobials, and the use of flunixin meglumine, a nonsteroidal anti-inflammatory drug commonly used in veterinary medicine to alleviate pain and inflammation.